GLP1R and type 2 diabetes mellitus: In agreement with these reports, our results indicate that eye drops containing GLP-1 were able to activate AMPK and inhibit NF-κB through a down-regulation of IKBα phosphorylation in the retina of a mouse model of spontaneous type 2 diabetes.